Sign up to save your podcastsEmail addressPasswordRegisterOrContinue with GoogleAlready have an account? Log in here.
December 21, 2017FDA D.I.S.C.O.: First biosimilar approval for the treatment of cancer8 minutesPlayFDA medical oncologists discuss the Sept 14, 2017, approval of MVASI, the first biosimilar approved in the US for the treatment of cancer....moreShareView all episodesBy U.S. Food and Drug Administration, Center for Drug Evaluation and Research4.41414 ratingsDecember 21, 2017FDA D.I.S.C.O.: First biosimilar approval for the treatment of cancer8 minutesPlayFDA medical oncologists discuss the Sept 14, 2017, approval of MVASI, the first biosimilar approved in the US for the treatment of cancer....more
FDA medical oncologists discuss the Sept 14, 2017, approval of MVASI, the first biosimilar approved in the US for the treatment of cancer.
December 21, 2017FDA D.I.S.C.O.: First biosimilar approval for the treatment of cancer8 minutesPlayFDA medical oncologists discuss the Sept 14, 2017, approval of MVASI, the first biosimilar approved in the US for the treatment of cancer....more
FDA medical oncologists discuss the Sept 14, 2017, approval of MVASI, the first biosimilar approved in the US for the treatment of cancer.